Skip to main content
Premium Trial:

Request an Annual Quote

Jochen Kohlhaas, Gerald Mller, Michael Kranich, Christof Hettich, Michael Meyer, and Expression Analysis

Premium

People in the News

Jochen Kohlhaas has become vice president for finance of Febit Biotech, the Heidelberg, Germany-based firm said last week. He holds a degree in business administration.

Febit also has named Gerald Möller, Michael Kranich, Christof Hettich, and Michael Meyer to serve as members on its new supervisory board.

Möller, a former president and CEO of the Boehringer Mannheim Group and a former member of Roche's executive board, will serve as president of Febit's advisory board.

Michael Kranich will serve as a representative of Febit core investors Dietmar Hopp and Oliver Hopp. Kranich is also the CEO of German venture capital firms DH Capital and OG Beteiligungen.

Hettich, of Rittershaus Mannheim, currently serves as Febit's law advisor, and Meyer is CEO of Technostart, another VC firm that has invested in Febit.

 

New Product Watch

Expression Analysis has concluded an upgrade of its laboratory systems to support new Affymetrix products, the company said last week.

According to EA, the upgrade includes the addition of Affymetrix 7G and MegAllele scanners, which in turn enable the array service provider to run Affy's Exon Arrays, 500K Mapping Array Set and the MegAllele DME-T assay developed by ParAllele Biosciences.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.